spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Biotech Showcase 2018

8-10 January 2018
Hilton San Francisco, Union Square, CA 94102 USA

Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.

The 2017 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in itstenthyear, Biotech Showcase 2017 is expected to feature presentations by close to 400 public and private companies and attract more than 3,000 attendees. The event will run a full program of topical plenary sessions and workshops, including special-focus events dedicated to emerging trends.

The demand for innovation in all areas of human health is the impetus behind Digital Medicine & Medtech Showcase, a focus event taking place during Biotech Showcase at Parc 55 in San Francisco. The event brings together key stakeholders at the convergence of traditional therapeutics, digital tools, combination products, companion diagnostics, precision medicine, AI and other technical advances to explore funding opportunities, partnerships and collaboration.

Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support services to the biotechnology industry.

Registration Contact:

Cassidy Hamilton
EBD Group
+1 760 930 0500
chamilton@ebdgroup.com


Catharine Moreno Finan

EBD Group

T: +49 89 23 88 756 25

cmoreno@ebdgroup.com

 
Print this page
Send to a friend
   
spacer
Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

White Papers

Managing GxP Environmental Systems to Ensure Data Integrity

Vaisala Ltd


More info >>


News and Press Releases

Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line maintenance treatment of patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the Phase III POLO trial, which were published in The New England Journal of Medicine.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement